Objectives

At the conclusion of this session, participants will be able to:

• Adopt current COPD treatment guidelines
• Recognize specific phenotypes of COPD in order to choose the preferred treatment options in different patients
• Recognise the potential benefit and adverse outcomes associated with the ICS component of Triple Therapy in COPD
• Become comfortable with the new triple combination inhalers being promoted for the treatment of COPD